Scarica l'app Stockscreener
2.86
0.35%
0.010
Dopo l'orario di chiusura:
2.88
0.02
+0.70%
Acumen Pharmaceuticals Inc Azioni (ABOS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
36.50%
26.51
|
41.75 | 30.37 | 39.60 | 32.27 |
| Operating Income/Loss |
36.50%
-26.51
|
-41.75 | -30.37 | -39.60 | -32.27 |
| Nonoperating Income/Loss |
92.25%
0.062
|
0.80 | 1.574 | 2.443 | 2.50 |
| Income/Loss From Continuing Operations Before Tax |
35.41%
-26.45
|
-40.95 | -28.80 | -37.15 | -29.77 |
| Income/Loss From Continuing Operations After Tax |
35.41%
-26.45
|
-40.95 | -28.80 | -37.15 | -29.77 |
|
Net Income/Loss
|
35.41%
-26.45
|
-40.95 | -28.80 | -37.15 | -29.77 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
60.57
|
60.57 | 60.53 | 0.0224 | 60.08 |
| Diluted Average Shares |
0.00%
60.57
|
60.57 | 60.53 | 0.0224 | 60.08 |
| Basic Earnings Per Share |
35.29%
-0.44
|
-0.68 | -0.48 | -0.62 | -0.50 |
| Diluted Earnings Per Share |
35.29%
-0.44
|
-0.68 | -0.48 | -0.62 | -0.50 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):